TOPIC 313 PHASE I; RNAI CANCER THERAPEUTICS USING NANOTECHNOLOGY; HHSN2612013000

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$200,000.00
Award Year:
2013
Program:
SBIR
Phase:
Phase I
Contract:
N43CA130030
Agency Tracking Number:
N43CA130030
Solicitation Year:
2013
Solicitation Topic Code:
NCI
Solicitation Number:
n/a
Small Business Information
GENESEGUES, INC.
GENESEGUES, INC., 3180 HIGH POINT DRIVE, CHASKA, MN, 55318-9476
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
95972415
Principal Investigator:
GRETCHEN UNGER
(952) 443-3798
GMU@GENESEGUES.COM
Business Contact:
GRETCHEN UNGER
(952) 443-3798
GMU@GENESEGUES.COM
Research Institution:
Stub




Abstract
The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer. PUBLIC HEALTH RELEVANCE

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government